Report Detail

Request for Sample of this report

Pharma & Healthcare Global NMDA Receptor Antagonist Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4626660
    • |
  • 10 September, 2025
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global NMDA Receptor Antagonist market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global NMDA Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global NMDA Receptor Antagonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global NMDA Receptor Antagonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global NMDA Receptor Antagonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global NMDA Receptor Antagonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for NMDA Receptor Antagonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global NMDA Receptor Antagonist market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Algernon Pharmaceuticals, Relmada Therapeutics, UCB, Avanir Pharmaceuticals, Axsome Therapeutics, Seelos Therapeutics, PharmaTher, Cessatech, ATAI Life Sciences, Small Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
NMDA Receptor Antagonist market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vaccine
Monoclonal Antibody
Market segment by Application
Parkinson's Disease
Alzheimer's Disease
Others
Major players covered
Algernon Pharmaceuticals
Relmada Therapeutics
UCB
Avanir Pharmaceuticals
Axsome Therapeutics
Seelos Therapeutics
PharmaTher
Cessatech
ATAI Life Sciences
Small Pharma
Bexson Biomedical
DemeRx
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe NMDA Receptor Antagonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of NMDA Receptor Antagonist, with price, sales quantity, revenue, and global market share of NMDA Receptor Antagonist from 2020 to 2025.
Chapter 3, the NMDA Receptor Antagonist competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NMDA Receptor Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and NMDA Receptor Antagonist market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of NMDA Receptor Antagonist.
Chapter 14 and 15, to describe NMDA Receptor Antagonist sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global NMDA Receptor Antagonist Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Vaccine
    • 1.3.3 Monoclonal Antibody
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global NMDA Receptor Antagonist Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Parkinson's Disease
    • 1.4.3 Alzheimer's Disease
    • 1.4.4 Others
  • 1.5 Global NMDA Receptor Antagonist Market Size & Forecast
    • 1.5.1 Global NMDA Receptor Antagonist Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global NMDA Receptor Antagonist Sales Quantity (2020-2031)
    • 1.5.3 Global NMDA Receptor Antagonist Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Algernon Pharmaceuticals
    • 2.1.1 Algernon Pharmaceuticals Details
    • 2.1.2 Algernon Pharmaceuticals Major Business
    • 2.1.3 Algernon Pharmaceuticals NMDA Receptor Antagonist Product and Services
    • 2.1.4 Algernon Pharmaceuticals NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Algernon Pharmaceuticals Recent Developments/Updates
  • 2.2 Relmada Therapeutics
    • 2.2.1 Relmada Therapeutics Details
    • 2.2.2 Relmada Therapeutics Major Business
    • 2.2.3 Relmada Therapeutics NMDA Receptor Antagonist Product and Services
    • 2.2.4 Relmada Therapeutics NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Relmada Therapeutics Recent Developments/Updates
  • 2.3 UCB
    • 2.3.1 UCB Details
    • 2.3.2 UCB Major Business
    • 2.3.3 UCB NMDA Receptor Antagonist Product and Services
    • 2.3.4 UCB NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 UCB Recent Developments/Updates
  • 2.4 Avanir Pharmaceuticals
    • 2.4.1 Avanir Pharmaceuticals Details
    • 2.4.2 Avanir Pharmaceuticals Major Business
    • 2.4.3 Avanir Pharmaceuticals NMDA Receptor Antagonist Product and Services
    • 2.4.4 Avanir Pharmaceuticals NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Avanir Pharmaceuticals Recent Developments/Updates
  • 2.5 Axsome Therapeutics
    • 2.5.1 Axsome Therapeutics Details
    • 2.5.2 Axsome Therapeutics Major Business
    • 2.5.3 Axsome Therapeutics NMDA Receptor Antagonist Product and Services
    • 2.5.4 Axsome Therapeutics NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Axsome Therapeutics Recent Developments/Updates
  • 2.6 Seelos Therapeutics
    • 2.6.1 Seelos Therapeutics Details
    • 2.6.2 Seelos Therapeutics Major Business
    • 2.6.3 Seelos Therapeutics NMDA Receptor Antagonist Product and Services
    • 2.6.4 Seelos Therapeutics NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Seelos Therapeutics Recent Developments/Updates
  • 2.7 PharmaTher
    • 2.7.1 PharmaTher Details
    • 2.7.2 PharmaTher Major Business
    • 2.7.3 PharmaTher NMDA Receptor Antagonist Product and Services
    • 2.7.4 PharmaTher NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 PharmaTher Recent Developments/Updates
  • 2.8 Cessatech
    • 2.8.1 Cessatech Details
    • 2.8.2 Cessatech Major Business
    • 2.8.3 Cessatech NMDA Receptor Antagonist Product and Services
    • 2.8.4 Cessatech NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Cessatech Recent Developments/Updates
  • 2.9 ATAI Life Sciences
    • 2.9.1 ATAI Life Sciences Details
    • 2.9.2 ATAI Life Sciences Major Business
    • 2.9.3 ATAI Life Sciences NMDA Receptor Antagonist Product and Services
    • 2.9.4 ATAI Life Sciences NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 ATAI Life Sciences Recent Developments/Updates
  • 2.10 Small Pharma
    • 2.10.1 Small Pharma Details
    • 2.10.2 Small Pharma Major Business
    • 2.10.3 Small Pharma NMDA Receptor Antagonist Product and Services
    • 2.10.4 Small Pharma NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Small Pharma Recent Developments/Updates
  • 2.11 Bexson Biomedical
    • 2.11.1 Bexson Biomedical Details
    • 2.11.2 Bexson Biomedical Major Business
    • 2.11.3 Bexson Biomedical NMDA Receptor Antagonist Product and Services
    • 2.11.4 Bexson Biomedical NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Bexson Biomedical Recent Developments/Updates
  • 2.12 DemeRx
    • 2.12.1 DemeRx Details
    • 2.12.2 DemeRx Major Business
    • 2.12.3 DemeRx NMDA Receptor Antagonist Product and Services
    • 2.12.4 DemeRx NMDA Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 DemeRx Recent Developments/Updates

3 Competitive Environment: NMDA Receptor Antagonist by Manufacturer

  • 3.1 Global NMDA Receptor Antagonist Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global NMDA Receptor Antagonist Revenue by Manufacturer (2020-2025)
  • 3.3 Global NMDA Receptor Antagonist Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of NMDA Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 NMDA Receptor Antagonist Manufacturer Market Share in 2024
    • 3.4.3 Top 6 NMDA Receptor Antagonist Manufacturer Market Share in 2024
  • 3.5 NMDA Receptor Antagonist Market: Overall Company Footprint Analysis
    • 3.5.1 NMDA Receptor Antagonist Market: Region Footprint
    • 3.5.2 NMDA Receptor Antagonist Market: Company Product Type Footprint
    • 3.5.3 NMDA Receptor Antagonist Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global NMDA Receptor Antagonist Market Size by Region
    • 4.1.1 Global NMDA Receptor Antagonist Sales Quantity by Region (2020-2031)
    • 4.1.2 Global NMDA Receptor Antagonist Consumption Value by Region (2020-2031)
    • 4.1.3 Global NMDA Receptor Antagonist Average Price by Region (2020-2031)
  • 4.2 North America NMDA Receptor Antagonist Consumption Value (2020-2031)
  • 4.3 Europe NMDA Receptor Antagonist Consumption Value (2020-2031)
  • 4.4 Asia-Pacific NMDA Receptor Antagonist Consumption Value (2020-2031)
  • 4.5 South America NMDA Receptor Antagonist Consumption Value (2020-2031)
  • 4.6 Middle East & Africa NMDA Receptor Antagonist Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global NMDA Receptor Antagonist Sales Quantity by Type (2020-2031)
  • 5.2 Global NMDA Receptor Antagonist Consumption Value by Type (2020-2031)
  • 5.3 Global NMDA Receptor Antagonist Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global NMDA Receptor Antagonist Sales Quantity by Application (2020-2031)
  • 6.2 Global NMDA Receptor Antagonist Consumption Value by Application (2020-2031)
  • 6.3 Global NMDA Receptor Antagonist Average Price by Application (2020-2031)

7 North America

  • 7.1 North America NMDA Receptor Antagonist Sales Quantity by Type (2020-2031)
  • 7.2 North America NMDA Receptor Antagonist Sales Quantity by Application (2020-2031)
  • 7.3 North America NMDA Receptor Antagonist Market Size by Country
    • 7.3.1 North America NMDA Receptor Antagonist Sales Quantity by Country (2020-2031)
    • 7.3.2 North America NMDA Receptor Antagonist Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe NMDA Receptor Antagonist Sales Quantity by Type (2020-2031)
  • 8.2 Europe NMDA Receptor Antagonist Sales Quantity by Application (2020-2031)
  • 8.3 Europe NMDA Receptor Antagonist Market Size by Country
    • 8.3.1 Europe NMDA Receptor Antagonist Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe NMDA Receptor Antagonist Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific NMDA Receptor Antagonist Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific NMDA Receptor Antagonist Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific NMDA Receptor Antagonist Market Size by Region
    • 9.3.1 Asia-Pacific NMDA Receptor Antagonist Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific NMDA Receptor Antagonist Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America NMDA Receptor Antagonist Sales Quantity by Type (2020-2031)
  • 10.2 South America NMDA Receptor Antagonist Sales Quantity by Application (2020-2031)
  • 10.3 South America NMDA Receptor Antagonist Market Size by Country
    • 10.3.1 South America NMDA Receptor Antagonist Sales Quantity by Country (2020-2031)
    • 10.3.2 South America NMDA Receptor Antagonist Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa NMDA Receptor Antagonist Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa NMDA Receptor Antagonist Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa NMDA Receptor Antagonist Market Size by Country
    • 11.3.1 Middle East & Africa NMDA Receptor Antagonist Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa NMDA Receptor Antagonist Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 NMDA Receptor Antagonist Market Drivers
  • 12.2 NMDA Receptor Antagonist Market Restraints
  • 12.3 NMDA Receptor Antagonist Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of NMDA Receptor Antagonist and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of NMDA Receptor Antagonist
  • 13.3 NMDA Receptor Antagonist Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 NMDA Receptor Antagonist Typical Distributors
  • 14.3 NMDA Receptor Antagonist Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on NMDA Receptor Antagonist. Industry analysis & Market Report on NMDA Receptor Antagonist is a syndicated market report, published as Global NMDA Receptor Antagonist Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of NMDA Receptor Antagonist market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo